Announcing the first class of Convergence Scholars.

Monday October 9, 2017. The Marble Center for Cancer Nanomedicine, established through a generous gift from Kathy and Curt Marble ’63, announced today the inaugural class of the Convergence Scholars Program. This announcement coincides with National Nanotechnology Day, an annual event featuring a series of community-led events and activities on October 9th to help raise awareness of nanotechnology. This date, 10/9, pays homage to the nanometer scale, 10-9 meters.

The Marble Center brings together leading faculty from the Koch Institute for Integrative Cancer Research at MIT to focus on grand challenges in cancer detection, treatment, and monitoring that could benefit from the emerging biology and physics of the nanoscale. The concept of “convergence” — the blending of the life and physical sciences with engineering — is a hallmark of MIT, the founding principle of the Koch Institute, and at the heart of the Marble Center’s mission.

The Convergence Scholars Program (CSP) aims at cultivating in postdoctoral trainees an integrative vision of science and technology. CSP will provide postdoctoral trainees with opportunities to further their experiences and skills beyond the research laboratory space. The inaugural class of Convergence Scholars represents the six Marble Center research groups within the Koch Institute.

(Click on each picture above to learn more about this year's Convergence scholars)

  • Dr. Kaitlyn Sadtler is a postdoctoral fellow at the Anderson Lab. Her research focuses on the creation of a resorbable bandage modified with small molecules to decrease fibrosis and promote healing in skin injury.
  • Dr. Briana Dunn is a postdoctoral associate at the Belcher Lab. Her research focuses on the creation of hybrid biological-inorganic catalysts. 
  • Dr. Liangliang Hao is a postdoctoral researcher at the Bhatia Lab. Her research focuses on the development of nanosensors for the precise imaging of colorectal cancer metastases.
  • Dr. Natalie Boehnke is a postdoctoral researcher at the Hammond Lab. Her research focuses on engineering protease-responsive “layer-by-layer” nanoparticles for targeted drug delivery applications.
  • Dr. Jacob Martin is a postdoctoral associate at the Irvine Lab. His research focuses on directing HIV antigen trafficking with immune complexes for vaccine applications.
  • Dr. Ritu Raman is a postdoctoral fellow at the Langer Lab. Her research focuses on building smart, responsive, and implantable devices for long-term sensing and drug delivery.